Lupin and Aurobindo Pharma's US units recall Cefixime and Dexamethasone products due to manufacturing issues per USFDA.
Lupin and Aurobindo Pharma's US-based units, Lupin Pharmaceuticals Inc and Eugia US LLC, are recalling products from the American market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). Lupin Pharmaceuticals is recalling 3,552 bottles of Cefixime for Oral Suspension, while Eugia US LLC is recalling 70,125 vials of Dexamethasone Sodium Phosphate injection USP.
June 23, 2024
4 Articles